A Pilot Study: Hypertension, Endothelial Dysfunction and Retinal Microvasculature in Rheumatic Autoimmune Diseases.
ADMA
connective tissue autoimmune diseases
early sign
endothelial dysfunction
hypertension
pulse wave velocity
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
09 Sep 2021
09 Sep 2021
Historique:
received:
17
07
2021
revised:
26
08
2021
accepted:
07
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
The etiology of autoimmune rheumatic diseases is unknown. Endothelial dysfunction and premature atherosclerosis are commonly seen in these patients. Atherosclerosis is considered one of the main causes of cardiovascular diseases. Hypertension is considered the most important traditional cardiovascular risk. This case-control study aimed to investigate the relationship between autoimmune diseases and cardiovascular risk. This study was carried out in patients with rheumatoid arthritis, RA ( A high prevalence of hypertension was seen in RA (80% of cases) and PSS (40% of cases) compared to controls (only 20% of cases). Significant changes were seen in MBP (RA 101 ± 11 mmHg; PSS 93 ± 10 mm Hg vs. controls 88 ± 7 mmHg, The prevalence of hypertension in our cohort was very high. Similarly, signs of endothelial dysfunction were seen in autoimmune rheumatic diseases. As hypertension and endothelial dysfunction are important contributing risk factors for cardiovascular diseases, the association of hypertension and endothelial dysfunction should be monitored closely in autoimmune diseases.
Sections du résumé
BACKGROUND
BACKGROUND
The etiology of autoimmune rheumatic diseases is unknown. Endothelial dysfunction and premature atherosclerosis are commonly seen in these patients. Atherosclerosis is considered one of the main causes of cardiovascular diseases. Hypertension is considered the most important traditional cardiovascular risk. This case-control study aimed to investigate the relationship between autoimmune diseases and cardiovascular risk.
METHODS
METHODS
This study was carried out in patients with rheumatoid arthritis, RA (
RESULTS
RESULTS
A high prevalence of hypertension was seen in RA (80% of cases) and PSS (40% of cases) compared to controls (only 20% of cases). Significant changes were seen in MBP (RA 101 ± 11 mmHg; PSS 93 ± 10 mm Hg vs. controls 88 ± 7 mmHg,
CONCLUSIONS
CONCLUSIONS
The prevalence of hypertension in our cohort was very high. Similarly, signs of endothelial dysfunction were seen in autoimmune rheumatic diseases. As hypertension and endothelial dysfunction are important contributing risk factors for cardiovascular diseases, the association of hypertension and endothelial dysfunction should be monitored closely in autoimmune diseases.
Identifiants
pubmed: 34575178
pii: jcm10184067
doi: 10.3390/jcm10184067
pmc: PMC8467719
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Hypertens. 2018 Dec 1;24:17
pubmed: 30519485
Curr Hypertens Rep. 2010 Dec;12(6):448-55
pubmed: 20857237
Lupus. 2006;15(2):80-6
pubmed: 16539278
Cardiovasc J Afr. 2021 May-Jun 23;32(3):133-140
pubmed: 33191430
Circulation. 2009 Nov 17;120(20):2012-24
pubmed: 19917895
Front Cardiovasc Med. 2019 Apr 09;6:41
pubmed: 31024934
Rheumatology (Oxford). 2011 May;50(5):939-43
pubmed: 21172929
Heart. 2016 May 15;102(10):790-5
pubmed: 26888573
Science. 1990 Jun 15;248(4961):1380-8
pubmed: 1972595
Arthritis Res. 2002;4(5):R5
pubmed: 12223108
Oxid Med Cell Longev. 2020 Apr 13;2020:1417981
pubmed: 32351667
J Clin Med. 2021 Jan 20;10(3):
pubmed: 33498530
Ann Rheum Dis. 2017 Jan;76(1):17-28
pubmed: 27697765
Nat Rev Rheumatol. 2011 May 31;7(7):399-408
pubmed: 21629241
Biochemistry (Mosc). 2016 Nov;81(11):1358-1370
pubmed: 27914461
Hypertension. 2005 Jul;46(1):194-9
pubmed: 15911740
Arthritis Res Ther. 2005;7(3):R634-43
pubmed: 15899050
Kidney Int. 2003 May;63(5):1934-43
pubmed: 12675874
Arthritis Rheumatol. 2020 Oct;72(10):1658-1667
pubmed: 32475073
J Hypertens. 2016 Aug;34(8):1492-3
pubmed: 27355996
Ann Rheum Dis. 2014 Jan;73(1):62-8
pubmed: 24095940
Curr Vasc Pharmacol. 2020;18(6):566-579
pubmed: 31985379
Circ Res. 2005 Sep 2;97(5):e53-9
pubmed: 16100045
Ann Intern Med. 2006 Feb 21;144(4):249-56
pubmed: 16490910
Angiology. 2018 Mar;69(3):228-235
pubmed: 28635303
J Cardiol. 2012 Jan;59(1):72-7
pubmed: 22079854
Circulation. 2006 Sep 12;114(11):1185-92
pubmed: 16952987
J Am Coll Cardiol. 2004 Oct 19;44(8):1636-40
pubmed: 15489096
Clin Exp Rheumatol. 2014 May-Jun;32(3):361-8
pubmed: 24565029
Front Pharmacol. 2017 Jul 12;8:460
pubmed: 28785220
J Physiol. 2005 Oct 15;568(Pt 2):357-69
pubmed: 16051630
J Nutr. 2004 Oct;134(10 Suppl):2842S-2847S; discussion 2853S
pubmed: 15465797
Autoimmun Rev. 2016 Jul;15(7):756-69
pubmed: 26979271
Diab Vasc Dis Res. 2007 Jun;4(2):130-5
pubmed: 17654447
Biomed Res Int. 2014;2014:367359
pubmed: 25177690
Rheumatology (Oxford). 2008 Jan;47(1):72-5
pubmed: 18077493
Expert Rev Respir Med. 2017 Dec;11(12):1021-1031
pubmed: 28978239
Arthritis Res Ther. 2018 Jun 8;20(1):123
pubmed: 29884228
BMC Med. 2014 Mar 18;12:47
pubmed: 24642015
Cell Mol Life Sci. 2016 Dec;73(24):4611-4622
pubmed: 27491297
Lymphology. 2020;53(3):109-117
pubmed: 33350285
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
Arthritis Rheum. 2001 Dec;44(12):2737-45
pubmed: 11762933
J Clin Invest. 2013 Feb;123(2):540-1
pubmed: 23485580
Hypertension. 2019 Dec;74(6):1436-1447
pubmed: 31679426
Sci Rep. 2021 Feb 25;11(1):4653
pubmed: 33633255
Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2208-2217
pubmed: 31108551
J Rheumatol. 2008 Mar;35(3):398-406
pubmed: 18203326
Rheumatology (Oxford). 2009 Dec;48(12):1553-6
pubmed: 19779028
Hypertension. 2010 May;55(5):1210-6
pubmed: 20308612
Arthritis Care Res (Hoboken). 2015 Apr;67(4):554-62
pubmed: 25303669
Arthritis Rheum. 2007 Mar;56(3):809-19
pubmed: 17328055
J Rheumatol. 2006 Nov;33(11):2167-72
pubmed: 16981296
Blood Press. 2017 Apr;26(2):115-121
pubmed: 27653044
Int J Mol Sci. 2014 Jun 25;15(7):11324-49
pubmed: 24968272
Ann Rheum Dis. 2007 Jan;66(1):28-33
pubmed: 16793841
Clin Rheumatol. 2019 Feb;38(2):447-455
pubmed: 30178172
Int J Rheum Dis. 2018 May;21(5):908-921
pubmed: 29671956
BMJ Open. 2021 Mar 17;11(3):e042955
pubmed: 33737426
Rheumatology (Oxford). 2008 Sep;47(9):1286-98
pubmed: 18467370
Front Immunol. 2018 Mar 26;9:541
pubmed: 29632529
Aging Dis. 2016 Jan 02;7(1):81-9
pubmed: 26815098
Sci Rep. 2017 Mar 15;7:44692
pubmed: 28294182
Coron Artery Dis. 2014 Dec;25(8):713-24
pubmed: 25365643
Arthritis Rheum. 2004 Nov;50(11):3444-9
pubmed: 15529391
Atherosclerosis. 2008 Feb;196(2):756-63
pubmed: 17266963
Curr Hypertens Rep. 2019 Feb 2;21(1):10
pubmed: 30712132
Ann N Y Acad Sci. 2005 Jun;1051:281-90
pubmed: 16126969
Anesth Analg. 2018 May;126(5):1763-1768
pubmed: 29481436
BMC Infect Dis. 2020 Jul 3;20(1):473
pubmed: 32620082
Arthritis Rheumatol. 2017 Jan;69(1):35-45
pubmed: 27785888
Arthritis Care Res (Hoboken). 2017 Feb;69(2):166-174
pubmed: 27159164
Lancet. 1992 Mar 7;339(8793):572-5
pubmed: 1347093
BMC Infect Dis. 2017 Jan 7;17(1):41
pubmed: 28061822
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Rheumatology (Oxford). 2007 Sep;46(9):1477-82
pubmed: 17704521
Curr Eye Res. 2013 Jun;38(6):685-90
pubmed: 23654356
Front Med (Lausanne). 2018 Dec 03;5:339
pubmed: 30560132
Am J Hypertens. 2003 Jul;16(7):537-43
pubmed: 12850386
Sci Rep. 2019 Apr 1;9(1):5426
pubmed: 30932011
J Hypertens. 2014 Feb;32(2):207-15
pubmed: 24322199
Curr Med Res Opin. 2007 Oct;23(10):2395-404
pubmed: 17714606